Chemotherapy for colorectal cancer is the use of cytotoxic or targeted drugs to destroy colorectal cancer cells or slow their growth, either as a primary treatment or alongside surgery and radiotherapy. The aim is to shrink tumours, eliminate residual disease after resection, control advanced or metastatic disease, …
Chemotherapy for colorectal cancer is the use of cytotoxic or targeted drugs to destroy colorectal cancer cells or slow their growth, either as a primary treatment or alongside surgery and radiotherapy. The aim is to shrink tumours, eliminate residual disease after resection, control advanced or metastatic disease, and reduce the risk of recurrence. Agents may be given orally or intravenously and are frequently combined into multi-drug regimens; treatment decisions depend on the cancer stage, tumour biology, and the patient's overall health. Chemotherapy is one element of a broader colorectal cancer care pathway that also encompasses screening, early detection, surgical management, and post-operative recovery. The journal Colon And Rectal Cancer publishes peer-reviewed research across this spectrum, including work on screening uptake and fecal immunochemical testing, surgical techniques and bowel reconstruction, tumour pathology and carcinogenesis, molecular diagnostics, and perioperative risk assessment. This page gathers open-access scholarship relevant to the diagnosis, treatment, and management of colorectal cancer, situating chemotherapy within the multidisciplinary effort to improve outcomes for affected patients. Readers seeking the specific drug regimens used in a given clinical setting should consult current oncology guidelines and qualified clinicians.
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 10 articles above have been cited 32 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Chemotherapy for Colorectal Cancer, linking to each citing work.